Matching slides 40,452
Current window 24,781-24,810
Pages 1,349
Rows per page 30

Beat

24,781-24,810 of 40,452

filter-aware
17
The slide includes a specific note regarding an accounting change for FLC revenue starting in Q2 2023.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
18
Includes a specific note regarding an accounting change (FLC) impacting revenue growth rates.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
19
The slide uses a combination of bar charts for revenue and a waterfall-style or negative-bar chart for EBITDA, highlighting margin percentages.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
20
The slide compares revenue trends and EBITDA margin improvements across five quarters.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
13
Includes specific revenue data for Mirena, Lo Loestrin, and NuvaRing as market benchmarks.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · Market Size1 hit
06
The slide uses a bar chart for market growth and a timeline to show the sequence of industry-wide price increases.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Market Size1 hit
11
The slide uses a structured table format to present KPIs alongside their YoY changes and contextual explanations.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials1 hit
12
The slide uses waterfall-style bridges to show YoY growth across two different dimensions.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials1 hit
13
The slide uses a stacked bar chart for subscriber breakdown and a simple bar chart for ARPU growth.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials1 hit
14
The chart uses a stacked bar format to show segment contributions to total adjusted gross profit, with variance annotations.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials1 hit
15
The chart illustrates a bridge between H1 2022 and H1 2023 adjusted gross profit after marketing.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
16
The chart uses a waterfall bridge to explain the variance in adjusted EBITDA.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
17
The chart uses a waterfall bridge to explain the movement in cash position over H1 2023.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials1 hit
19
Deezer | Results Presentation Deck | 31 slidesDeezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Why Now1 hit
20
Deezer | Results Presentation Deck | 31 slidesDeezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Why Now1 hit
11
The chart uses a waterfall-style additive visualization to show how three distinct market segments combine to form the total TAM.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
12
The slide uses a waffle chart (icon grid) to represent 430 individual brands, color-coded by revenue penetration level.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
15
The slide uses a combination of bar charts for absolute values and line charts for percentage margins.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · Financials1 hit
16
The slide presents two distinct tables: one for cash flow (left) and one for net debt (right).Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · Financials1 hit
17
The slide uses a structured layout to compare four distinct market segments (Cutaneous T cell Lymphoma, Alopecia Areata, Vitiligo, Atopic Dermatitis) with specific patient counts and clinical status.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
18
The slide uses a four-column structure to explain the target, the molecule type, preclinical results, and clinical results.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
35
The slide combines individual team member bios with a collective logo grid of past affiliations.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Team1 hit
36
The slide uses a Gantt-style timeline to show the duration of IP protection for various therapeutic assets.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Team1 hit
13
The slide combines a biological pathway diagram (mechanism of action) with a clinical trial summary table.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
Includes two waterfall plots comparing patient responses; source cited as Novartis materials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
16
Waterfall plot uses standard clinical trial terminology (PD, SD, PR). Comparison table highlights the study drug's performance against Dacarbazine and Binimetinib.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
17
The slide uses a before-and-after visual comparison to demonstrate clinical efficacy.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
Swimmer plot visualization of clinical trial data (Trial LXH254X2102).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
19
The slide highlights consistent clinical activity across two study phases, culminating in a combined ORR of 33.3%.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit